1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Extra Renal Origin: new trials by email Literature Review of Extra Renal Origin trials Research Report on Extra Renal Origin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas Nivolumab, Ipilimumab - Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Active not recruiting | Brown University | 46 | 2018-04-30 | 2026-08-20 |
Adenocarcinoma, Clear Cell (1) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Recurrence (1)
Adenocarcinoma (1) · Adnexal Diseases (1) · Carcinoma (1) · Disease Attributes (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Fallopian Tube Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Ipilimumab (1) · Nivolumab (1)
Brown University (1)
United States (1)
Don Dizon, MD (1)